Fox Run Management L.L.C. bought a new stake in shares of LifeStance Health Group, Inc. (NASDAQ:LFST – Free Report) in the 4th quarter, according to its most recent 13F filing with the Securities and Exchange Commission (SEC). The fund bought 19,434 shares of the company’s stock, valued at approximately $143,000.
Several other institutional investors have also added to or reduced their stakes in the business. Blue Trust Inc. raised its holdings in LifeStance Health Group by 124.4% in the 4th quarter. Blue Trust Inc. now owns 3,828 shares of the company’s stock worth $27,000 after purchasing an additional 2,122 shares during the period. Zurcher Kantonalbank Zurich Cantonalbank lifted its position in shares of LifeStance Health Group by 31.4% during the 3rd quarter. Zurcher Kantonalbank Zurich Cantonalbank now owns 24,105 shares of the company’s stock valued at $169,000 after buying an additional 5,767 shares in the last quarter. The Manufacturers Life Insurance Company grew its stake in shares of LifeStance Health Group by 10.5% during the 3rd quarter. The Manufacturers Life Insurance Company now owns 81,741 shares of the company’s stock valued at $572,000 after acquiring an additional 7,798 shares during the period. Rhumbline Advisers increased its holdings in LifeStance Health Group by 4.5% in the 4th quarter. Rhumbline Advisers now owns 195,581 shares of the company’s stock worth $1,441,000 after acquiring an additional 8,487 shares in the last quarter. Finally, Charles Schwab Investment Management Inc. lifted its holdings in LifeStance Health Group by 0.8% during the fourth quarter. Charles Schwab Investment Management Inc. now owns 1,113,499 shares of the company’s stock valued at $8,206,000 after purchasing an additional 9,046 shares in the last quarter. 85.50% of the stock is currently owned by institutional investors.
Insider Buying and Selling
In other LifeStance Health Group news, insider Lisa K. Miller sold 18,845 shares of LifeStance Health Group stock in a transaction on Monday, March 17th. The shares were sold at an average price of $6.90, for a total value of $130,030.50. Following the sale, the insider now directly owns 339,810 shares in the company, valued at approximately $2,344,689. The trade was a 5.25 % decrease in their position. The sale was disclosed in a legal filing with the SEC, which is accessible through this link. 6.60% of the stock is owned by company insiders.
LifeStance Health Group Trading Down 1.0 %
Analyst Upgrades and Downgrades
A number of analysts have recently issued reports on LFST shares. William Blair reissued an “outperform” rating on shares of LifeStance Health Group in a research note on Friday, February 28th. The Goldman Sachs Group upgraded LifeStance Health Group from a “neutral” rating to a “buy” rating and set a $10.00 price target for the company in a research note on Monday, December 16th. One equities research analyst has rated the stock with a sell rating, one has issued a hold rating and three have given a buy rating to the company’s stock. Based on data from MarketBeat, LifeStance Health Group has an average rating of “Hold” and an average target price of $8.63.
View Our Latest Stock Report on LifeStance Health Group
LifeStance Health Group Profile
LifeStance Health Group, Inc, through its subsidiaries, provides outpatient mental health services to children, adolescents, adults, and geriatrics in the United States. The company offers patients a suite of mental health services, including psychiatric evaluations and treatment, psychological, and neuropsychological testing, as well as individual, family, and group therapy.
See Also
- Five stocks we like better than LifeStance Health Group
- How to Invest in the Best Canadian Stocks
- Why Dollar Tree’s Family Dollar Sale Could Spark a Comeback
- Manufacturing Stocks Investing
- JPMorgan: The ‘NVIDIA of Banking’ Poised for More Gains?
- How to find penny stocks to invest and trade
- Buy the Chewy Stock Reversal? Here’s Why Now Is the Time
Want to see what other hedge funds are holding LFST? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for LifeStance Health Group, Inc. (NASDAQ:LFST – Free Report).
Receive News & Ratings for LifeStance Health Group Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for LifeStance Health Group and related companies with MarketBeat.com's FREE daily email newsletter.